MXCT

1.3858.20%
JG

Jay Gelfman

Chief Operations Officer

Mr. Jay Gelfman was Senior Vice President of Operations of MaxCyte, Inc. from 2024 until April 2026 and serves as Chief Operations Officer since April 2026. Mr. Gelfman’s diverse experience as a cross-functional finance, information technology and operations leader has allowed him to guide numerous organizations through successful business transformations. Previously, he was the Senior Director of Financial Planning and Analysis at MaxCyte after serving in several leadership positions of increasing responsibility at Innate Pharma, AstraZeneca, MedImmune and Accenture. Mr. Gelfman earned a Master of Business Administration in finance and information systems from the University of Maryland’s Robert H. Smith School of Business after receiving a Bachelor of Science in finance from the Smeal College of Business at Penn State University.

Positions